Thousands of deals were announced globally through 2012, and this level of confidence and activity in M&A continues apace into 2013 as exemplified by Valeant’s acquisition of Ambi Skincare Products from Johnson & Johnson and Acne Free from University Medical. Similarly, Valeant has recently announced it is acquiring outstanding Obagi stock for $360 million. Other noteworthy